Ayala Pharmaceuticalsの機関の所有権

Ayala Pharmaceuticalsの機関の所有権は何ですか。

Ayala Pharmaceuticals Inc.の機関の所有権は0.10%です。

機関の所有権の定義は何ですか。



機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

NASDAQのセクタHealth Careにおける機関の所有権の企業と比べるAyala Pharmaceuticals

Ayala Pharmaceuticalsは何をしますか。

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Ayala Pharmaceuticalsと類似の機関の所有権